The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Tiffany Y.T. Hsu, Lukas M. Simon, Nicholas J. Neill, Richard Marcotte, Azin Sayad, Christopher S. Bland, Gloria V. Echeverria, Tingting Sun, Sarah J. Kurley, Siddhartha Tyagi, Kristen L. Karlin, Rocio Dominguez-Vidaña, Jessica D. Hartman, Alexander Renwick, Kathleen Scorsone, Ronald J. Bernardi, Samuel O. Skinner, Antrix Jain, Mayra Orellana, Chandraiah LagisettiIdo Golding, Sung Y. Jung, Joel R. Neilson, Xiang H.F. Zhang, Thomas A. Cooper, Thomas R. Webb, Benjamin G. Neel, Chad A. Shaw, Thomas F. Westbrook

Research output: Contribution to journal › Article › peer-review

346 Scopus citations

Fingerprint

Dive into the research topics of 'The spliceosome is a therapeutic vulnerability in MYC-driven cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences